TY - JOUR
T1 - ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases
AU - Radtke, Thomas
AU - Crook, Sarah
AU - Kaltsakas, Georgios
AU - Louvaris, Zafeiris
AU - Berton, Danilo
AU - Urquhart, Don S.
AU - Kampouras, Asterios
AU - Rabinovich, Roberto A.
AU - Verges, Samuel
AU - Kontopidis, Dimitris
AU - Boyd, Jeanette
AU - Tonia, Thomy
AU - Langer, Daniel
AU - De Brandt, Jana
AU - Goërtz, Yvonne M.J.
AU - Burtin, Chris
AU - Spruit, Martijn A.
AU - Braeken, Dionne C.W.
AU - Dacha, Sauwaluk
AU - Franssen, Frits M.E.
AU - Laveneziana, Pierantonio
AU - Eber, Ernst
AU - Troosters, Thierry
AU - Neder, J. Alberto
AU - Puhan, Milo A.
AU - Casaburi, Richard
AU - Vogiatzis, Ioannis
AU - Hebestreit, Helge
PY - 2019/12/31
Y1 - 2019/12/31
N2 - The objective of this document was to standardise published cardiopulmonary exercise testing (CPET) protocols for improved interpretation in clinical settings and multicentre research projects. This document: 1) summarises the protocols and procedures used in published studies focusing on incremental CPET in chronic lung conditions; 2) presents standard incremental protocols for CPET on a stationary cycle ergometer and a treadmill; and 3) provides patients' perspectives on CPET obtained through an online survey supported by the European Lung Foundation. We systematically reviewed published studies obtained from EMBASE, Medline, Scopus, Web of Science and the Cochrane Library from inception to January 2017. Of 7914 identified studies, 595 studies with 26 523 subjects were included. The literature supports a test protocol with a resting phase lasting at least 3 min, a 3-min unloaded phase, and an 8- to 12-min incremental phase with work rate increased linearly at least every minute, followed by a recovery phase of at least 2textendash3 min. Patients responding to the survey (n=295) perceived CPET as highly beneficial for their diagnostic assessment and informed the Task Force consensus. Future research should focus on the individualised estimation of optimal work rate increments across different lung diseases, and the collection of robust normative data.The document facilitates standardisation of conducting, reporting and interpreting cardiopulmonary exercise tests in chronic lung diseases for comparison of reference data, multi-centre studies and assessment of interventional efficacy. http://bit.ly/31SXeB5
AB - The objective of this document was to standardise published cardiopulmonary exercise testing (CPET) protocols for improved interpretation in clinical settings and multicentre research projects. This document: 1) summarises the protocols and procedures used in published studies focusing on incremental CPET in chronic lung conditions; 2) presents standard incremental protocols for CPET on a stationary cycle ergometer and a treadmill; and 3) provides patients' perspectives on CPET obtained through an online survey supported by the European Lung Foundation. We systematically reviewed published studies obtained from EMBASE, Medline, Scopus, Web of Science and the Cochrane Library from inception to January 2017. Of 7914 identified studies, 595 studies with 26 523 subjects were included. The literature supports a test protocol with a resting phase lasting at least 3 min, a 3-min unloaded phase, and an 8- to 12-min incremental phase with work rate increased linearly at least every minute, followed by a recovery phase of at least 2textendash3 min. Patients responding to the survey (n=295) perceived CPET as highly beneficial for their diagnostic assessment and informed the Task Force consensus. Future research should focus on the individualised estimation of optimal work rate increments across different lung diseases, and the collection of robust normative data.The document facilitates standardisation of conducting, reporting and interpreting cardiopulmonary exercise tests in chronic lung diseases for comparison of reference data, multi-centre studies and assessment of interventional efficacy. http://bit.ly/31SXeB5
U2 - 10.1183/16000617.0101-2018
DO - 10.1183/16000617.0101-2018
M3 - Article
SN - 0905-9180
VL - 28
JO - European Respiratory Review
JF - European Respiratory Review
IS - 154
M1 - 180101
ER -